TYRA
Price:
$16.39
Market Cap:
$864.35M
Tyra Biosciences, Inc., a preclinical-stage biopharmaceutical company, focuses on developing therapies to overcome tumor resistance and enhance outcomes for patients with cancer. Its lead product candidate is TYRA-300, a selective inhibitor of fibroblast growth factor receptor (FGFR)3 for the treatment of muscle invasive bladder cancer. The company is also developing programs targeting FGFR2- intrahepatic cholangiocarcinoma,FGFR3-related achondroplasia, REarranged during transfection kinase, and FGFR4-related cancers. In addition, the company offers SNAP platform which enable rapid structural design through iterative molecular SNAPshots. Tyra Biosciences, Inc. was incorporated in 2018 and is...[Read more]
Industry
Biotechnology
IPO Date
2021-09-15
Stock Exchange
NASDAQ
Ticker
TYRA
According to Tyra Biosciences, Inc.’s latest financial reports and current stock price. The company's current ROE is -27.13%. This represents a change of 257.74% compared to the average of -7.58% of the last 4 quarters.
The mean historical ROE of Tyra Biosciences, Inc. over the last ten years is 33.09%. The current -27.13% ROE has changed -182.00% with respect to the historical average. Over the past ten years (40 quarters), TYRA's ROE was at its highest in in the December 2020 quarter at 27.02%. The ROE was at its lowest in in the December 2022 quarter at -20.37%.
Average
33.09%
Median
54.05%
Minimum
-33.85%
Maximum
85.59%
Discovering the peaks and valleys of Tyra Biosciences, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual ROE = 85.59%
Minimum Annual Increase = -723.87%
Minimum Annual ROE = -33.85%
Year | ROE | Change |
---|---|---|
2023 | -33.85% | -162.62% |
2022 | 54.05% | -723.87% |
2021 | -8.66% | -112.69% |
2020 | 68.29% | -20.21% |
The current ROE of Tyra Biosciences, Inc. (TYRA) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
3.85%
5-year avg
33.09%
10-year avg
33.09%
Tyra Biosciences, Inc.’s ROE is less than Connect Biopharma Holdings Limited (7.21%), greater than RAPT Therapeutics, Inc. (-86.04%), greater than Xilio Therapeutics, Inc. (-176.51%), greater than Mineralys Therapeutics, Inc. (-42.61%), greater than Gracell Biotechnologies Inc. (-37.20%), greater than Theseus Pharmaceuticals, Inc. (-24.51%), greater than Monte Rosa Therapeutics, Inc. (-70.40%), greater than Design Therapeutics, Inc. (-18.48%), greater than Erasca, Inc. (-131.94%), greater than Werewolf Therapeutics, Inc. (-48.25%), greater than Ikena Oncology, Inc. (-42.81%), greater than Stoke Therapeutics, Inc. (-57.89%), greater than PMV Pharmaceuticals, Inc. (-21.96%), greater than Pharvaris N.V. (-36.89%), greater than Molecular Partners AG (-33.08%), greater than Century Therapeutics, Inc. (-65.37%), greater than Edgewise Therapeutics, Inc. (-28.01%), greater than C4 Therapeutics, Inc. (-42.45%), greater than Cullinan Oncology, Inc. (-28.37%),
Company | ROE | Market cap |
---|---|---|
7.21% | $65.20M | |
-86.04% | $77.83M | |
-176.51% | $58.02M | |
-42.61% | $668.82M | |
-37.20% | $989.87M | |
-24.51% | $181.50M | |
-70.40% | $546.22M | |
-18.48% | $294.43M | |
-131.94% | $768.41M | |
-48.25% | $108.38M | |
-42.81% | $83.00M | |
-57.89% | $677.05M | |
-21.96% | $83.98M | |
-36.89% | $1.30B | |
-33.08% | $240.19M | |
-65.37% | $106.74M | |
-28.01% | $3.19B | |
-42.45% | $388.98M | |
-28.37% | $914.87M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Tyra Biosciences, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Tyra Biosciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Tyra Biosciences, Inc.'s ROE?
How is the ROE calculated for Tyra Biosciences, Inc. (TYRA)?
What is the highest ROE for Tyra Biosciences, Inc. (TYRA)?
What is the 3-year average ROE for Tyra Biosciences, Inc. (TYRA)?
What is the 5-year average ROE for Tyra Biosciences, Inc. (TYRA)?
How does the current ROE for Tyra Biosciences, Inc. (TYRA) compare to its historical average?